Physician profile
Vannette Perkins
NPI 1104801430
$4,178.62
in general payments reported to CMS, 2019-2025
31 companies · $542 in 2025
The $542 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,122 · 2020: $160 · 2021: $559 · 2022: $167 · 2023: $135 · 2024: $494 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,662.80 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $581.02 | 2019-2025 | Belbuca |
| Abbott Laboratories | $314.77 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $251.58 | 2021-2025 | General - Pain Management, Patient Trial Kit |
| Medtronic USA, INC. | $181.19 | 2019 | |
| Biodelivery Sciences International, INC. | $177.72 | 2019-2021 | |
| Daiichi Sankyo INC. | $112.22 | 2019 | |
| Medtronic, INC. | $99.22 | 2024-2025 | Vanta Adaptivestim, Intellis Adaptivestim |
| Si-Bone, INC. | $94.96 | 2021-2024 | |
| Mdd US Operations, LLC | $75.90 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $75.77 | 2023-2025 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $54.48 | 2019-2021 | |
| Uswm, LLC | $53.44 | 2021 | |
| Protega Pharmaceutials INC | $47.04 | 2024 | Roxybond |
| Saluda Medical Americas, INC. | $42.10 | 2025 | Evoke |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $39.86 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.45 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $34.01 | 2019 | |
| Tersera Therapeutics LLC | $29.36 | 2019 | |
| Zyla Life Sciences, INC. | $26.47 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $25.01 | 2019 | |
| Biotronik Nro, INC. | $24.80 | 2024 | Prospera |
| Globus Medical, INC. | $23.66 | 2025 | Senza |
| Exact Sciences Corporation | $22.58 | 2025 | Cologuard Collection Kit |
| Redhill Biopharma INC. | $14.91 | 2021 | |
| Ibsa Pharma INC. | $14.66 | 2023 | Tirosint, Licart |
| Almatica Pharma LLC | $13.87 | 2021 | |
| Spr Therapeutics, INC | $12.66 | 2024 | Sprint Pns System |
| Virtus Pharmaceuticals LLC | $12.20 | 2021 | |
| Pfizer INC. | $11.84 | 2019 | |
| Horizon Therapeutics Plc | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vannette Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.